`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Conde,Dominick <DConde@fchs.com>
`Thursday, August 20, 2015 11:11 AM
`Trials
`Mandra,Raymond; Murthy, Sanjay K. (sanjay.murthy@klgates.com); Abernathy, Michael
`J.; Kerrane, Sara N. (sara.kerrane@klgates.com); Nair, Margaux
`(Margaux.Nair@klgates.com); Doukas, Maria E (Maria.Doukas@klgates.com); Roberts,
`Melinda; uspto
`Initial Conference
`
`Dear Board:
`
`Pursuant to the Board’s July 30, 2015 Case Management and Scheduling Order (Paper 13) in IPR2015‐00529, Patent
`Owner INO Therapeutics LLC requests an initial conference call to discuss scheduling and procedural posture of the IPR.
`
`In particular, Patent Owner has a conflict with the March 24, 2016 date for oral argument and would also like to discuss
`the unique posture of this IPR given the Board’s claim construction.
`
`Due to commitments on other matters, Counsel for Patent Owner is not available for the initial conference call from
`August 26‐28.
`
`Respectfully submitted,
`
`Dominick A. Conde
`FITZPATRICK, CELLA, HARPER & SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`T 212-218-2204
`F 212-218-2200
`DConde@fchs.com
`http://www.fitzpatrickcella.com
`Bio
`
`
`
`---------------------------------------------------------------------------
`This email message and any attachments are intended for the use of the
`addressee(s)indicated above. Information that is privileged or otherwise
`confidential may be contained therein. If you are not the intended recipient(s),
`you are hereby notified that any dissemination, review or use of this message,
`documents or information contained therein is strictly prohibited. If you have
`received this message in error, please immediately delete it and notify us by
`telephone at (212) 218-2100. Thank you.
`
`1